Clinical Trial Update: Baricitinib in the Treatment of Kohlmeier-Degos Disease in Patients With Neurological Involvement [Phase 2]

View source ↗

Summary

This clinical trial update shows that baricitinib is being studied in a Phase 2 trial for Degos disease with neurological involvement and is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degos Disease

Drugs mentioned

• Baricitinib (baricitinib)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Kohlmeier-Degos Disease, Malignant Atrophic Papulosis | Phase 2 | Status: RECRUITING